N@N

Furiex Pharmaceuticals Announces Third Quarter 2010 Earnings Release, Webcast and Conference Call

^{Published on 2010-10-06 11:56:03 - Market Wire}
 

MORRISVILLE, N.C.--([ BUSINESS WIRE ])--Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) will release its third quarter 2010 financial results on Wednesday, November 10, 2010, after the market closes. The earnings news release will be available on the Furiex website at [ www.furiex.com ].

On Thursday, November 11, 2010, at 9 a.m. ET, Furiex will conduct a live conference call and audio webcast to discuss its financial results and product portfolio. A Q&A session will follow. The conference call will be broadcast live over the Internet and will also be available using the following direct dial numbers:

All interested parties can access the webcast through the Presentations & Events link in the Investors section of the Furiex website at [ www.furiex.com ]. The webcast will be archived shortly after the call for on-demand replay.

About Furiex Pharmaceuticals

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by advancing them through the drug discovery and development process in a cost-efficient manner. Development programs are designed and driven by a core team with extensive drug development experience. The company collaborates with pharmaceutical and biotechnology companies and has a strong, diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and two products on the market. The companya™s mission is to develop innovative medicines faster and at less cost, reducing the expense of health care globally while providing life-improving therapies for patients. For more information, visit [ www.furiex.com ].